Cargando…
Update on systemic treatment for newly diagnosed inflammatory breast cancer
BACKGROUND: Inflammatory breast cancer (IBC) is a rare and aggressive disease, accounting for 2–4% of new cases of breast cancer. Owing to its aggressive nature, IBC represent approximately 8–10% of breast cancer deaths. Management of IBC requires a multidisciplinary team for decision-making involvi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020152/ https://www.ncbi.nlm.nih.gov/pubmed/33842000 http://dx.doi.org/10.1016/j.jare.2020.08.014 |